Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • FITC Goat Anti-Rabbit IgG (H+L) Antibody: Benchmarks, Mec...

    2026-02-12

    FITC Goat Anti-Rabbit IgG (H+L) Antibody: Mechanism, Evidence, and Application Benchmarks

    Executive Summary: The FITC Goat Anti-Rabbit IgG (H+L) Antibody is an affinity-purified, polyclonal reagent for robust detection of rabbit IgG in immunofluorescence, immunohistochemistry, and flow cytometry (APExBIO K1203). It is conjugated to fluorescein isothiocyanate (FITC), enabling sensitive signal amplification and quantitative detection in research workflows (Peng et al., 2024). The antibody is produced by immunizing goats with pooled rabbit IgG, followed by affinity purification and conjugation, ensuring high specificity and low background. Benchmarking studies confirm its application in biomarker discovery, including diabetic nephropathy proteomics. Proper usage and storage parameters are essential for maintaining reagent stability and fluorescence integrity.

    Biological Rationale

    Secondary antibodies are critical tools in immunodetection workflows, providing signal amplification and specificity in the visualization of primary antibody targets. The FITC Goat Anti-Rabbit IgG (H+L) Antibody binds specifically to the heavy and light chains of rabbit IgG molecules, enabling detection of rabbit-derived primary antibodies across a range of assay formats (see precision immunofluorescence). This reagent is conjugated with FITC, a well-characterized fluorophore that emits green fluorescence (excitation: ~495 nm, emission: ~519 nm) under standard conditions, facilitating quantitative and multiplexed detection in cell and tissue imaging (APExBIO product page).

    Biomarker discovery in proteomics, particularly for diseases such as diabetic nephropathy, relies on sensitive, reproducible detection of protein targets in complex samples (Peng et al., 2024). Mass spectrometry-based workflows and immunoassays often employ such secondary antibodies for enhanced signal and robust quantification.

    Mechanism of Action of FITC Goat Anti-Rabbit IgG (H+L) Antibody

    The FITC Goat Anti-Rabbit IgG (H+L) Antibody is produced by immunizing goats with purified rabbit IgG. The resulting polyclonal antibodies are affinity purified to enrich for high-specificity immunoglobulins targeting both heavy and light chains. FITC is covalently attached to the antibody via isothiocyanate chemistry, resulting in a fluorescent conjugate.

    In a typical immunoassay, the primary antibody (rabbit origin) binds the antigen of interest. The FITC-conjugated secondary antibody recognizes and binds to the Fc or Fab regions of the primary antibody. This enables multiple secondary antibodies to associate with a single primary antibody, amplifying the fluorescent signal proportionally (see strategic amplification). FITC’s fluorescence is then detected using fluorescence microscopy, flow cytometry, or compatible plate readers.

    The antibody is supplied as a 1 mg/mL solution in PBS with 23% glycerol, 1% BSA, and 0.02% sodium azide. This formulation supports stability during shipping at 4°C and storage for up to 12 months at -20°C, provided freeze/thaw cycles are avoided and the product is protected from light (APExBIO K1203).

    Evidence & Benchmarks

    • Affinity-purified FITC Goat Anti-Rabbit IgG (H+L) Antibody enables sensitive detection of rabbit IgG in immunofluorescence and immunohistochemistry at concentrations as low as 0.5–2 μg/mL (https://www.apexbt.com/fitc-goat-anti-rabbit-igg-h-l-antibody.html).
    • Benchmark studies in quantitative serum proteomics for diabetic nephropathy used similar FITC-conjugated secondary antibodies to validate biomarker expression, supporting reproducibility in translational workflows (Peng et al., 2024, DOI).
    • The antibody demonstrates minimal cross-reactivity and background staining in both tissue and cell-based assays when used at recommended dilutions, as documented in comparative immunofluorescence protocols (see biomarker discovery review).
    • Signal amplification via secondary antibody binding increases detection sensitivity by up to 5–10x over direct labeling methods, supporting identification of low-abundance targets (see protocol enhancements).
    • FITC-conjugated secondary antibodies remain stable for at least 12 months at -20°C in 23% glycerol and 1% BSA, with less than 10% loss in fluorescence intensity (APExBIO datasheet, product page).

    Applications, Limits & Misconceptions

    The FITC Goat Anti-Rabbit IgG (H+L) Antibody is validated for immunofluorescence, flow cytometry, and immunohistochemistry, where rabbit primary antibodies are used. It is suitable for detection of both denatured and native antigens, provided the epitope is accessible. In biomarker research, such as the identification of HMGB1 in diabetic nephropathy, secondary antibodies are essential for sensitive validation of proteomics findings (Peng et al., 2024).

    This article extends prior reviews by systematically mapping evidence from peer-reviewed translational biomarker studies, such as Peng et al. (2024), to practical immunodetection workflows, going beyond the protocol focus in recent scenario-based Q&A.

    Common Pitfalls or Misconceptions

    • Not suitable for detection of primary antibodies from species other than rabbit; cross-reactivity with mouse, goat, or human IgG is minimal but not zero.
    • FITC fluorescence is sensitive to photobleaching; prolonged light exposure reduces signal.
    • Repeated freeze/thaw cycles degrade antibody structure and fluorescence.
    • High background may result from insufficient blocking or incorrect dilution; always optimize blocking conditions and use recommended dilutions.
    • The antibody does not confer specificity for the antigen; specificity is determined by the primary antibody.

    Workflow Integration & Parameters

    Recommended dilutions for immunofluorescence and immunohistochemistry typically range from 1:200 to 1:1000, corresponding to 0.5–5 μg/mL, depending on signal requirements and sample complexity. For flow cytometry, titration is essential to balance signal-to-noise ratio. The reagent’s glycerol and BSA formulation protects against freeze/thaw damage, while sodium azide inhibits microbial contamination; however, sodium azide is toxic and may inhibit horseradish peroxidase (HRP) in enzyme-linked assays.

    Store at 4°C for up to 2 weeks for short-term use, or aliquot and store at -20°C for up to 12 months for long-term stability. Avoid repeated freeze/thaw cycles. Protect from light at all times to preserve FITC fluorescence.

    For detailed troubleshooting, advanced protocol enhancements, and application-driven insights, see this in-depth guide—this article adds a benchmarking focus and incorporates recent clinical biomarker research.

    Conclusion & Outlook

    The FITC Goat Anti-Rabbit IgG (H+L) Antibody from APExBIO is a robust, validated reagent for fluorescence-based antibody detection. Its affinity-purified, FITC-conjugated format enables highly sensitive and reproducible signal amplification in immunofluorescence, flow cytometry, and immunohistochemistry. Benchmark studies, including those in quantitative proteomics for biomarker discovery, affirm its reproducibility and versatility in translational research (Peng et al., 2024). Proper workflow integration and handling are essential for optimal results. As noninvasive biomarker detection becomes central to clinical diagnostics, reliable secondary antibodies like the K1203 kit will remain foundational tools in biomedical research.